Results 151 to 160 of about 178,280 (162)

An Increase in Circulating B Cell–Activating Factor in Childhood-Onset Ocular Myasthenia Gravis

Pediatric Neurology, 2015
Yozo Nakazawa, Mitsuo Motobayashi, Yuji Inaba   +2 more
exaly  

Ocular myasthenia gravis in a senior population: Diagnosis, therapy, and prognosis

Muscle and Nerve, 2010
Jeffrey A Allen, H Royden Jones
exaly  

The effect of early prednisolone treatment on the generalization rate in ocular myasthenia gravis

European Journal of Neurology, 2013
Håkan Cetin, Fritz Zimprich, E Auff
exaly  

Introduction to myasthenia gravis and ocular myasthenia gravis

Jaimin R. Shah, Viralkumar Patel, Harshil Shah   +2 more
openaire   +1 more source

Prognostic factors and health-related quality of life in ocular myasthenia gravis (OMG)

International Journal of Neuroscience, 2014
Francesca Benuzzi, Giuliana Galassi, Alessandra Ariatti   +2 more
exaly  

Factors affecting outcome in ocular myasthenia gravis

International Journal of Neuroscience, 2018
Paolo Frigio Nichelli, Shaniko Kaleci, Giuliana Galassi   +2 more
exaly  

Different molecular expression in thymoma with ocular or generalized myasthenia gravis

Journal of the Neurological Sciences, 2012
Jun Guo, Zhuyi Li, Hongzeng Li
exaly  

Ocular Myasthenia Gravis

American Journal of Ophthalmology, 1949
openaire   +1 more source

Clinical Utility of Acetylcholine Receptor Antibody Testing in Ocular Myasthenia Gravis

JAMA Neurology, 2015
Eric R Eggenberger, Crandall Peeler, João Lemos   +2 more
exaly  

Case report: Efgartigimod is a novel therapeutic option for ocular myasthenia gravis: a report of 2 cases

Frontiers in Immunology
Ruixia Zhu
exaly